Treatment of HBeAg negative chronic hepatitis B with new drugs (adefovir and others)

J Hepatol. 2003:39 Suppl 1:S172-6. doi: 10.1016/s0168-8278(03)00334-9.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Arabinofuranosyluracil / analogs & derivatives*
  • Arabinofuranosyluracil / therapeutic use
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / therapeutic use
  • Emtricitabine
  • Guanine / analogs & derivatives*
  • Guanine / therapeutic use
  • Hepatitis B e Antigens / analysis*
  • Hepatitis B, Chronic / drug therapy*
  • Hepatitis B, Chronic / immunology*
  • Humans
  • Nucleosides / therapeutic use
  • Organophosphonates*

Substances

  • Antiviral Agents
  • Hepatitis B e Antigens
  • Nucleosides
  • Organophosphonates
  • Deoxycytidine
  • Arabinofuranosyluracil
  • entecavir
  • Guanine
  • adefovir
  • Emtricitabine
  • clevudine
  • Adenine